Allianz Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $233M | Buy |
301,196
+132,582
| +79% | +$102M | 0.24% | 77 |
|
|
2025
Q4 | $130M | Buy |
168,614
+152,202
| +927% | +$103M | 0.13% | 147 |
|
|
2025
Q3 | $9.23M | Sell |
16,412
-13,975
| -46% | -$7.9M | 0.01% | 872 |
|
|
2025
Q2 | $16M | Sell |
30,387
-16,333
| -35% | -$9.12M | 0.02% | 658 |
|
|
2025
Q1 | $29.6M | Sell |
46,720
-12,574
| -21% | -$8.65M | 0.04% | 454 |
|
|
2024
Q4 | $42.2M | Sell |
59,294
-15,329
| -21% | -$12.9M | 0.06% | 340 |
|
|
2024
Q3 | $78.4M | Sell |
74,623
-34,576
| -32% | -$38.5M | 0.11% | 205 |
|
|
2024
Q2 | $115M | Sell |
109,199
-14,751
| -12% | -$14.3M | 0.17% | 126 |
|
|
2024
Q1 | $119M | Sell |
123,950
-28,361
| -19% | -$27M | 0.18% | 127 |
|
|
2023
Q4 | $134M | Sell |
152,311
-6,282
| -4% | -$5.17M | 0.22% | 95 |
|
|
2023
Q3 | $131M | Buy |
158,593
+2,400
| +2% | +$1.89M | 0.22% | 85 |
|
|
2023
Q2 | $112M | Sell |
156,193
-78,242
| -33% | -$60.3M | 0.2% | 110 |
|
|
2023
Q1 | $193M | Sell |
234,435
-52
| -0% | -$39.2K | 0.34% | 56 |
|
|
2022
Q4 | $169M | Sell |
234,487
-18,241
| -7% | -$13.5M | 0.33% | 66 |
|
|
2022
Q3 | $174M | Sell |
252,728
-22,136
| -8% | -$13.9M | 0.35% | 56 |
|
|
2022
Q2 | $162M | Sell |
274,864
-14,757
| -5% | -$9.59M | 0.15% | 143 |
|
|
2022
Q1 | $202M | Buy |
289,621
+30,707
| +12% | +$19.4M | 0.15% | 148 |
|
|
2021
Q4 | $164M | Buy |
258,914
+12,549
| +5% | +$7.72M | 0.11% | 196 |
|
|
2021
Q3 | $149M | Buy |
246,365
+840
| +0.3% | +$521K | 0.12% | 193 |
|
|
2021
Q2 | $137M | Buy |
245,525
+105,869
| +76% | +$53.6M | 0.12% | 182 |
|
|
2021
Q1 | $66.1M | Buy |
139,656
+28,176
| +25% | +$13.7M | 0.06% | 299 |
|
|
2020
Q4 | $53.9M | Sell |
111,480
-6,811
| -6% | -$3.68M | 0.05% | 337 |
|
|
2020
Q3 | $66.2M | Sell |
118,291
-13,709
| -10% | -$8.31M | 0.08% | 268 |
|
|
2020
Q2 | $82.3M | Sell |
132,000
-18,648
| -12% | -$10.6M | 0.1% | 224 |
|
|
2020
Q1 | $73.6M | Sell |
150,648
-1,239
| -0.8% | -$511K | 0.1% | 223 |
|
|
2019
Q4 | $57M | Buy |
151,887
+33,344
| +28% | +$11.2M | 0.05% | 401 |
|
|
2019
Q3 | $32.9M | Buy |
118,543
+7,913
| +7% | +$2.34M | 0.03% | 581 |
|
|
2019
Q2 | $34.6M | Sell |
110,630
-5,858
| -5% | -$1.95M | 0.03% | 570 |
|
|
2019
Q1 | $47.8M | Buy |
116,488
+52,759
| +83% | +$21.7M | 0.05% | 410 |
|
|
2018
Q4 | $23.7M | Buy |
63,729
+20,478
| +47% | +$7.5M | 0.03% | 632 |
|
|
2018
Q3 | $17.5M | Sell |
43,251
-19,106
| -31% | -$7.27M | 0.02% | 973 |
|
|
2018
Q2 | $21.5M | Sell |
62,357
-16,252
| -21% | -$5.08M | 0.02% | 838 |
|
|
2018
Q1 | $27.1M | Sell |
78,609
-126,293
| -62% | -$43.9M | 0.03% | 710 |
|
|
2017
Q4 | $77M | Buy |
204,902
+53,292
| +35% | +$21.6M | 0.06% | 382 |
|
|
2017
Q3 | $67.8M | Buy |
151,610
+13,265
| +10% | +$6.31M | 0.06% | 389 |
|
|
2017
Q2 | $69.3M | Sell |
138,345
-26,901
| -16% | -$11.8M | 0.07% | 349 |
|
|
2017
Q1 | $64M | Buy |
165,246
+28,603
| +21% | +$10.6M | 0.06% | 384 |
|
|
2016
Q4 | $50.2M | Buy |
136,643
+19,732
| +17% | +$7.5M | 0.04% | 546 |
|
|
2016
Q3 | $47.3M | Sell |
116,911
-10,903
| -9% | -$4.37M | 0.05% | 491 |
|
|
2016
Q2 | $44.6M | Buy |
127,814
+63,443
| +99% | +$24.4M | 0.05% | 474 |
|
|
2016
Q1 | $23.2M | Sell |
64,371
-11,736
| -15% | -$4.84M | 0.03% | 719 |
|
|
2015
Q4 | $41.5M | Sell |
76,107
-37,464
| -33% | -$20.3M | 0.05% | 462 |
|
|
2015
Q3 | $52.8M | Buy |
113,571
+4,255
| +4% | +$2.29M | 0.06% | 360 |
|
|
2015
Q2 | $55.8M | Sell |
109,316
-3,284
| -3% | -$1.6M | 0.06% | 391 |
|
|
2015
Q1 | $50.8M | Buy |
112,600
+9,354
| +9% | +$3.96M | 0.06% | 360 |
|
|
2014
Q4 | $42.4M | Buy |
103,246
+45,616
| +79% | +$17.9M | 0.05% | 430 |
|
|
2014
Q3 | $20.8M | Buy |
57,630
+42,399
| +278% | +$14.2M | 0.03% | 625 |
|
|
2014
Q2 | $4.3M | Sell |
15,231
-97,876
| -87% | -$29M | 0.01% | 975 |
|
|
2014
Q1 | $34M | Buy |
113,107
+20,305
| +22% | +$6.26M | 0.04% | 423 |
|
|
2013
Q4 | $25.5M | Sell |
92,802
-14,776
| -14% | -$4.25M | 0.03% | 483 |
|
|
2013
Q3 | $33.7M | Buy |
107,578
+7,155
| +7% | +$1.88M | 0.04% | 415 |
|
|
2013
Q2 | $22.6M | Buy |
+100,423
| New | +$23.4M | 0.03% | 468 |
|
Other funds holding REGN
VCM
N
Allianz Asset Management's REGN Position: Q1 2026 in Review
Allianz Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 79% in Q1 2026, buying an estimated $102M and bringing the position to 301,196 shares worth $233M. The position accounts for 0.24% of the portfolio, ranked #77.
Allianz Asset Management first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Allianz Asset Management held 301,196 shares of Regeneron Pharmaceuticals worth $233M as of Q1 2026.
- Allianz Asset Management bought 132,582 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $102M.
- Regeneron Pharmaceuticals made up 0.24% of Allianz Asset Management's portfolio in Q1 2026, its #77 holding.
- Allianz Asset Management first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.